Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)

Authors

Usama Gergis MD, MBA, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

11-2024

Volume

144

Issue

1

Published In/Presented At

https://doi.org/10.1182/blood-2024-194807

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article